应用核苷类似物治疗慢加急性乙型肝炎肝衰竭患者短期疗效观察

doi:10.3969/j.issn.1672-5069.2015.04.022

Abstract

Wu Jiazhen，Yang Xingxiang，Jiang Nan，et al.. Short-term observation of nucleoside analogues therapy in patients with acute- on- chronic hepatitis B liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 413-414.

References

[1] Lu FM，Zhuang H. Management of hepatitis B in China. Chin Med J （Engl），2009，122（1）：3-4.
[2] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南.实用肝脏病杂志，2013，16（3）：210-216.
[3] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志，2011，14（2）：81-89.
[4] 中华医学会肝病学分会和传染病与寄生虫病学分会.病毒性肝炎防治方案. 中华肝脏病杂志，2000，8（6）：324-328.
[5] Kamath PS，Wiesner RH，MalinchocM，et al. A model to predict survival in patients with end-stage liver disease. Hepatology，2001，33（2）:464-470.
[6] 刘晓燕，胡瑾华，王慧芬，等. 1977 例急性、亚急性、慢加急性肝衰竭患者的病因与转归分析. 中华肝脏病杂志，2008，16（10）：772-775.
[7] 于乐成. 慢加急性肝衰竭. 肝脏，2007，12（2）：135-137.
[8] Roayaie S，Haim MB，Emre S，et al. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C:a western experience. Ann Surg Oncol，2000，7（10）:764-770.
[9] Koike Y，Shiratori Y，Sato S，et al. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion. Hepatology，2000，32（6）:1216-1223.
[11] Chen G，Lin W，Shen F，et al. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol，2006，10（8）:1797-1803.
[12] 郜玉峰，吴玲. MELD 评分在终末期肝病中的应用. 实用肝脏病杂志，2010，13（5）：393-396.
[13] Malincho CM，Kamath PS，Gordon FD，et al. A model to predict poor survival inpatients undergoing trans jugular intrahepatic portosystemic shunts.Hepatology，2000，31:864-871.
[14] Breuhahn K，Longerich T，Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene，2006，25（27）:3787-3800.
[15] Kuo C Y，Wang J C，Hsu S L，et al. HBx inhibits the growth of CCL13-HBX-stable cells via the GSK-3beta/beta-catenin cascade. Intervirology，2008，51（2）:130-136.
[16] Liu X，Wang L，Zhang S，et al. Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells:cDNA microarray and proteomic analyses. Carcinogenesis，2008，29（6）:1207-1214.
[17] Rossmanith W，Schulte-Hermann R. Biology of transforming growth factor beta in hepatocarcinogenesis. Microsc Res Tech，2001，52（4）:430-436.
[18] Fransvea E，Mazzocca A，Antonaci S，et al. Targeting transforming growth factor（TGF）-betaRI inhibits activation of betal integrin and blocks vascular invasion in hepatocellular carcinoma. Hepatology，2009，49（3）:839-850.
[19] Su K，Chen F，Yan WM，et al. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. World J Gastroenterol，2008，14（39）:5980-5989.
[20] Merion RM，Wolfe RA，Dykstra DM，et al. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl，2003，9（1）:12-18.
[21] 刘晓燕，胡瑾华，王慧芬. 乙型肝炎病毒感染所致慢加急性肝衰竭的临床预后分析. 中华肝脏病杂志，2009，17（8）：607-610.
[22] Cui YL，Yan F，Wang YB，et al. Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure. Dig Dis Sci， 2010，55（8）：2373-2380.

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[4]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[5]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[6]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[7]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[8]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[9]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[10]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[11]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[12]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[13]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[14]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[15]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.

Short-term observation of nucleoside analogues therapy in patients with acute- on- chronic hepatitis B liver failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments